Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine
- Author
- BABA, E1 ; NAKAMURA, M1 ; TANAKA, Y; KUROKI, M1 ; ITOYAMA, Y; NAKANO, S1 ; NIHO, Y1
[1] Kyushu univ., fac. medicine, first dep. internal medicine, Fukuoka 812, Japan - Source
The Journal of immunology (1950). 1993, Vol 151, Num 2, pp 1013-1024 ; ref : 52 ref
- CODEN
- JOIMA3
- ISSN
- 0022-1767
- Scientific domain
- Biochemistry, molecular biology, biophysics; Immunology, immunopathology, allergology
- Publisher
- American Association of Immunologists, Bethesda, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticorps monoclonal Antigénicité Cartographie Déterminant antigénique Glycoprotéine Homme Immunodominance Lymphocyte B Neutralisation Spécificité Vaccin Virus HTLV1 Retroviridae Virus
- Keyword (en)
- Monoclonal antibody Antigenicity Cartography Antigenic determinant Glycoproteins Human Immunodominance B-Lymphocyte Neutralization Specificity Vaccine HTLV-I virus Retroviridae Virus
- Keyword (es)
- Anticuerpo monoclonal Antigenicidad Cartografía Determinante antigénico Glicoproteina Hombre Inmunodominancia Linfocito B Neutralización Especificidad Vacuna HTLV-I virus Retroviridae Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C07 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies
- Discipline
- Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 4896210
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.4049/jimmunol.151.2.1013 
https://dx.doi.org/10.4049/jimmunol.151.2.1013
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:9:\"\u0000*\u0000jtitle\";s:32:\"The Journal of immunology (1950)\";s:9:\"\u0000*\u0000stitle\";s:18:\"J. immunol. (1950)\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:3:\"151\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:4:\"1013\";s:8:\"\u0000*\u0000epage\";s:4:\"1024\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1767\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BABA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:11:\"NAKAMURA, M\";i:1;s:9:\"TANAKA, Y\";i:2;s:9:\"KUROKI, M\";i:3;s:10:\"ITOYAMA, Y\";i:4;s:9:\"NAKANO, S\";i:5;s:7:\"NIHO, Y\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:37:\"American Association of Immunologists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:9:\"\u0000*\u0000jtitle\";s:32:\"The Journal of immunology (1950)\";s:9:\"\u0000*\u0000stitle\";s:18:\"J. immunol. (1950)\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:3:\"151\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:4:\"1013\";s:8:\"\u0000*\u0000epage\";s:4:\"1024\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1767\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BABA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:11:\"NAKAMURA, M\";i:1;s:9:\"TANAKA, Y\";i:2;s:9:\"KUROKI, M\";i:3;s:10:\"ITOYAMA, Y\";i:4;s:9:\"NAKANO, S\";i:5;s:7:\"NIHO, Y\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:37:\"American Association of Immunologists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:9:\"\u0000*\u0000jtitle\";s:32:\"The Journal of immunology (1950)\";s:9:\"\u0000*\u0000stitle\";s:18:\"J. immunol. (1950)\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:3:\"151\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:4:\"1013\";s:8:\"\u0000*\u0000epage\";s:4:\"1024\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1767\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BABA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:11:\"NAKAMURA, M\";i:1;s:9:\"TANAKA, Y\";i:2;s:9:\"KUROKI, M\";i:3;s:10:\"ITOYAMA, Y\";i:4;s:9:\"NAKANO, S\";i:5;s:7:\"NIHO, Y\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:37:\"American Association of Immunologists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:9:\"\u0000*\u0000jtitle\";s:32:\"The Journal of immunology (1950)\";s:9:\"\u0000*\u0000stitle\";s:18:\"J. immunol. (1950)\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:3:\"151\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:4:\"1013\";s:8:\"\u0000*\u0000epage\";s:4:\"1024\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1767\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BABA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:11:\"NAKAMURA, M\";i:1;s:9:\"TANAKA, Y\";i:2;s:9:\"KUROKI, M\";i:3;s:10:\"ITOYAMA, Y\";i:4;s:9:\"NAKANO, S\";i:5;s:7:\"NIHO, Y\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:37:\"American Association of Immunologists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.4049\/jimmunol.151.2.1013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:9:\"\u0000*\u0000jtitle\";s:32:\"The Journal of immunology (1950)\";s:9:\"\u0000*\u0000stitle\";s:18:\"J. immunol. (1950)\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:3:\"151\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:4:\"1013\";s:8:\"\u0000*\u0000epage\";s:4:\"1024\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1767\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BABA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:11:\"NAKAMURA, M\";i:1;s:9:\"TANAKA, Y\";i:2;s:9:\"KUROKI, M\";i:3;s:10:\"ITOYAMA, Y\";i:4;s:9:\"NAKANO, S\";i:5;s:7:\"NIHO, Y\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Multiple neutralizing B-cell epitopes of human T-cell leukelmia virus type 1 (HTLV-1) identified by human monoclonal antibodies : a basis for the design of an HTLV-1 peptide vaccine\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:37:\"American Association of Immunologists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
